BASAGLAR

Google image searchProduct monograph

Active ingredient

insulin glargine, 100 UNIT/ML

DIN: 02444844

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: CARTRIDGE

Schedule: Schedule D

Company: ELI LILLY CANADA INC

Date: 18-DEC-2015

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AE — Insulins and analogues for injection, long-acting (ATC, ATC/DDD)
• A10AE04 — INSULIN GLARGINE (ATC/DDD)

Reference brand drug: Lantus, Basaglar, Semglee, Toujeo

Pharmaceutical standard: USP

External Links for Basaglar

Search on Google

• Basaglar side effects
• Basaglar dosage
• insulin glargine side effects
• insulin glargine dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find basaglar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.